{"id":6320,"date":"2022-06-22T16:22:52","date_gmt":"2022-06-22T08:22:52","guid":{"rendered":"https:\/\/www.eisai.com.cn\/?p=6320"},"modified":"2022-11-30T16:27:18","modified_gmt":"2022-11-30T08:27:18","slug":"%e5%8d%ab%e6%9d%90%e5%9c%a8%e5%90%8c%e8%a1%8c%e8%af%84%e8%ae%ae%e6%9c%9f%e5%88%8a%e3%80%8a%e7%a5%9e%e7%bb%8f%e7%97%85%e5%ad%a6%e4%b8%8e%e6%b2%bb%e7%96%97%e3%80%8b%e4%b8%8a%e5%8f%91%e8%a1%a8%e4%ba%86","status":"publish","type":"post","link":"https:\/\/www.eisai.com.cn\/2022\/06\/22\/%e5%8d%ab%e6%9d%90%e5%9c%a8%e5%90%8c%e8%a1%8c%e8%af%84%e8%ae%ae%e6%9c%9f%e5%88%8a%e3%80%8a%e7%a5%9e%e7%bb%8f%e7%97%85%e5%ad%a6%e4%b8%8e%e6%b2%bb%e7%96%97%e3%80%8b%e4%b8%8a%e5%8f%91%e8%a1%a8%e4%ba%86\/","title":{"rendered":"\u536b\u6750\u5728\u540c\u884c\u8bc4\u8bae\u671f\u520a\u300a\u795e\u7ecf\u75c5\u5b66\u4e0e\u6cbb\u7597\u300b\u4e0a\u53d1\u8868\u4e86\u8bd5\u9a8c\u6027LECANEMAB\u7684\u6f5c\u5728\u7ecf\u6d4e\u4ef7\u503c"},"content":{"rendered":"
<\/p>\n
\u536b\u6750\u682a\u5f0f\u4f1a\u793e\uff08\u603b\u90e8\uff1a\u4e1c\u4eac\uff0c\u9996\u5e2d\u6267\u884c\u5b98\uff1a\u5185\u85e4\u6674\u592b\uff0c\u4ee5\u4e0b\u7b80\u79f0\u201c\u536b\u6750\u201d\uff09\u4eca\u65e5\u5ba3\u5e03\u5176\u5728\u540c\u884c\u8bc4\u8bae\u671f\u520a\u300a\u795e\u7ecf\u75c5\u5b66\u4e0e\u6cbb\u7597\u300b\u4e0a\u53d1\u8868\u4e86\u4e00\u9879\u65e9\u671f\u8bc4\u4f30\u7684\u7ed3\u679c\uff0c\u8be5\u8bc4\u4f30\u65e8\u5728\u4f7f\u7528\u7ecf\u9a8c\u8bc1\u7684\u75be\u75c5\u6a21\u62df\u6a21\u578b–AD Archimedes Condition Event\uff08AD ACE\uff09\u6a21\u578b1,2,3<\/sup>\uff0c\u4ece\u7f8e\u56fd\u533b\u4fdd\u652f\u4ed8\u65b9\u548c\u793e\u4f1a\u7684\u89d2\u5ea6\u6765\u4f30\u8ba1\u6297\u03b2\u6dc0\u7c89\u6837\u86cb\u767d\uff08A\u03b2\uff09\u539f\u7ea4\u7ef4\u6297\u4f53Lecanemab\u5728\u6cbb\u7597\u65e9\u671f\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\uff08AD\uff09\u60a3\u8005\u7684\u6f5c\u5728\u7ecf\u6d4e\u4ef7\u503c\u3002\u8fd9\u662f\u7b2c\u4e8c\u7bc7\u5173\u4e8eLecanemab\u6f5c\u5728\u4ef7\u503c\u7684\u6587\u7ae0\uff0c\u4e0a\u4e00\u7bc7\u662f\u5173\u4e8e\u4f7f\u7528\u6a21\u62df\u6a21\u578b\u5bf9Lecanemab\u7684\u957f\u671f\u5065\u5eb7\u7ed3\u5c40\u8fdb\u884c\u8bc4\u4ef7\uff0c\u4e8e2022\u5e744\u6708\u5728\u300a\u795e\u7ecf\u75c5\u5b66\u4e0e\u6cbb\u7597\u300b\u4e0a\u53d1\u88684<\/sup>\u3002\u533b\u4fdd\u652f\u4ed8\u65b9\u89d2\u5ea6\u91cd\u70b9\u5173\u6ce8\u76f4\u63a5\u62a4\u7406\u8d39\u7528\uff08\u5982\u95e8\u8bca\u548c\u4f4f\u9662\u670d\u52a1\u3001\u836f\u7269\u3001\u5e72\u9884\u6cbb\u7597\u8d39\u7528\u3001\u7597\u517b\u9662\u548c\u5c45\u5bb6\u533b\u7597\u4fdd\u5065\u670d\u52a1\uff09\uff0c\u793e\u4f1a\u89d2\u5ea6\u5219\u8fdb\u4e00\u6b65\u8003\u8651\u4e86\u793e\u4f1a\u6210\u672c\uff08\u5982\u751f\u4ea7\u529b\u635f\u5931\u548c\u975e\u6b63\u5f0f\u62a4\u7406\u8d39\u7528\uff09\u3002\u5982\u4e4b\u524d\u4e00\u7bc7\u6587\u7ae0\u6240\u8ff0\uff0c\u4e0e\u6807\u51c6\u6cbb\u7597*\uff08SoC\uff09\u76f8\u6bd4\uff0c\u5728SoC\u57fa\u7840\u4e0a\u52a0\u7528Lecanemab\uff08Lecanemab+SoC\uff09\u6cbb\u7597\u7684\u4e2a\u4f53\u4ece\u57fa\u7ebf\u5230\u8f7b\u5ea6\u3001\u4e2d\u5ea6\u548c\u91cd\u5ea6AD\u7684\u75be\u75c5\u8fdb\u5c55\u53ef\u80fd\u4f1a\u51cf\u7f13\uff0c\u5e73\u5747\u51cf\u7f13\u65f6\u95f4\u5206\u522b\u4e3a2.51\u5e74\u30013.13\u5e74\u548c2.34\u5e74\u3002\u8fd9\u79cd\u57fa\u4e8e\u6a21\u578b\u7684\u6a21\u62df\u521d\u6b65\u7ed3\u679c\u53ef\u80fd\u4f1a\u5ef6\u957f\u8d28\u91cf\u8c03\u6574\u751f\u547d\u5e74\uff08QALY**\uff09\uff0c\u5e76\u51cf\u5c11\u6b63\u5f0f\u548c\u975e\u6b63\u5f0f\u62a4\u7406\u8d39\u7528***\u3002\u6b64\u5916\uff0c\u672c\u7814\u7a76\u4e2d\u4f7f\u7528\u7684AD ACE\u6a21\u578b\u6846\u67b6\u6709\u52a9\u4e8e\u8bc4\u4f30Lecanemab\u5728\u4e0d\u540c\u60c5\u51b5\u4e0b\u7684\u6f5c\u5728\u4ef7\u503c\u4ee5\u53ca\u8fdb\u884c\u654f\u611f\u6027\u5206\u6790\uff0c\u5305\u62ec\u60a3\u8005\u5b50\u96c6\u3001\u66ff\u4ee3\u6cbb\u7597\u505c\u6b62\u89c4\u5219****\u3001\u6f5c\u5728\u7ed9\u836f\u65b9\u6848\u4ee5\u53ca\u4e3b\u8981\u4e0d\u786e\u5b9a\u6027\u6765\u6e90\u7684\u5f71\u54cd\u3002<\/p>\n \u536b\u6750\u7814\u53d1\u7684Lecanemab\uff0c\u65e8\u5728\u6539\u5584\u8111\u4e2d\u5df2\u5b58\u5728\u6dc0\u7c89\u6837\u75c5\u53d8\u7684\u65e9\u671fAD\u60a3\u8005\u7684\u9884\u540e\uff0c\u540c\u65f6\u81f4\u529b\u4e8e\u5f00\u5c55\u548c\u5206\u4eab\u76f8\u5173\u7814\u7a76\u7684\u4e34\u5e8a\u5206\u6790\u548c\u793e\u4f1a\u7ecf\u6d4e\u5b66\u5206\u6790\u3002\u4e3a\u6b64\uff0c\u536b\u6750\u5e0c\u671b\u4e3a\u5229\u76ca\u76f8\u5173\u8005\u4ece\u793e\u4f1a\u89d2\u5ea6\u8ba8\u8bbaLecanemab\u7684\u6f5c\u5728\u4e34\u5e8a\u4ef7\u503c\u548c\u793e\u4f1a\u7ecf\u6d4e\u5b66\u4ef7\u503c\u63d0\u4f9b\u57fa\u7840\uff0c\u5e76\u6682\u65f6\u4e0d\u4e3aLecanemab\u5b9a\u4ef7\u3002<\/p>\n \u8fd9\u4e00\u57fa\u4e8e\u6a21\u578b\u7684\u6a21\u62df\u5229\u7528\u4e86IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08\u7814\u7a76<\/u>201<\/u>\uff09\u7684\u7ed3\u679c\uff0c\u8be5\u8bd5\u9a8c\u8bc4\u4ef7\u4e86Lecanemab\u7528\u4e8e\u5df2\u5b58\u5728\u6dc0\u7c89\u6837\u75c5\u53d8\u7684\u65e9\u671fAD\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u5e76\u5df2\u53d1\u8868\u3002\u5176\u8fd8\u6839\u636e\u4e34\u5e8a\u548c\u7ecf\u6d4e\u5ba1\u67e5\u7814\u7a76\u6240\uff08ICER\uff09*****\u7684\u5efa\u8bae\uff0c\u5728\u5e7f\u6cdb\u7684\u652f\u4ed8\u610f\u613f\u9608\u503c\u8303\u56f4\uff0850,000\u7f8e\u5143-200,000\u7f8e\u5143\/QALY\uff09\u5185\u4f30\u8ba1\u4e86Lecanemab+SoC\u7684\u6f5c\u5728\u7ecf\u6d4e\u4ef7\u503c\u3002\u4ece\u533b\u4fdd\u652f\u4ed8\u65b9\u89d2\u5ea6\u6765\u770b\uff0c\u5bf9\u4e8e\u786e\u8ba4\u5b58\u5728\u6dc0\u7c89\u6837\u75c5\u53d8\u7684\u65e9\u671fAD\u60a3\u8005\u6765\u8bf4\uff0c\u76f8\u6bd4\u4e8eSoC\uff0c\u9884\u8ba1Lecanemab+SoC\u5c06\u589e\u52a00.61 QALY\uff0c\u975e\u6cbb\u7597\u603b\u8d39\u7528\u5c06\u51cf\u5c118,707\u7f8e\u5143\/\u4eba\uff08\u793e\u4f1a\u89d2\u5ea6\uff1a\u589e\u52a00.64 QALY\uff0c\u51cf\u5c1111,214\u7f8e\u5143\uff09\u3002\u6839\u636e\u8fd9\u4e00\u65e9\u671f\u7ecf\u6d4e\u8bc4\u4ef7\uff0c\u4f30\u8ba1Lecanemab\u7684\u6f5c\u5728\u5e74\u5ea6\u4ef7\u503c\u5bfc\u5411\u5b9a\u4ef7(VBP)\u4e3a9,249-35,605\u7f8e\u5143\uff08\u793e\u4f1a\u89d2\u5ea6\uff1a10,400-38,053\u7f8e\u5143\uff09\u3002<\/p>\n ICER\u7684\u4ef7\u503c\u6846\u67b65<\/sup>\u8868\u660e\uff0c\u4e0d\u80fd\u4ec5\u6839\u636e\u4e34\u5e8a\u548c\u6210\u672c\u6548\u76ca\u6307\u6807\u6765\u8861\u91cf\u4ef7\u503c\uff0c\u56e0\u6b64\u5728\u8bc4\u4f30\u957f\u671f\u4ef7\u503c\u65f6\uff0c\u8fd8\u8981\u5728\u6846\u67b6\u4e2d\u52a0\u5165\u5bf9\u80cc\u666f\u56e0\u7d20\u4ee5\u53ca\u5176\u4ed6\u83b7\u76ca\u548c\u4e0d\u5229\u56e0\u7d20\u7684\u8003\u91cf\u3002\u76f8\u5bf9\u4e8e\u76f4\u63a5\u533b\u7597\u8d39\u7528\u800c\u8a00\uff0cAD\u8fd8\u7ed9\u793e\u4f1a\u9020\u6210\u4e86\u5de8\u5927\u8d1f\u62c5\uff0c\u8fd9\u53ef\u80fd\u5bfc\u81f4\u5728\u4f30\u8ba1Lecanemab\u7684\u5408\u7406\u4ef7\u683c\u65f6\u91c7\u7528\u793e\u4f1a\u89c6\u89d2\u5e76\u63d0\u9ad8\u5e7f\u6cdb\u652f\u4ed8\u610f\u613f\u9608\u503c\u8303\u56f4\u7684\u4e0a\u9650\u3002<\/p>\n \u8bb8\u591aAD\u60a3\u8005\u63a5\u53d7\u4e86\u5bb6\u4eba\u548c\u670b\u53cb\u7684\u975e\u6b63\u5f0f\u62a4\u7406\uff0c2021\u5e74\u7f8e\u56fd\u65e0\u507f\u62a4\u7406\u603b\u65f6\u95f4\u8d85\u8fc7160\u4ebf\u5c0f\u65f6\uff0c\u4ef7\u503c2716\u4ebf\u7f8e\u51436<\/sup>\u3002\u8fd9\u4e9b\u9884\u6d4b\u548c\u6a21\u62df\u7ed3\u679c\u8868\u660e\uff0c\u65e9\u671f\u4f7f\u7528Lecanemab\u6cbb\u7597\u53ef\u80fd\u4f1a\u51cf\u5c11\u6b64\u7c7b\u6210\u672c\u548c\u7ecf\u6d4e\u8d1f\u62c5\uff0c\u5e76\u4e3a\u533b\u7597\u4fdd\u5065\u51b3\u7b56\u8005\u63d0\u4f9b\u6709\u5173Lecanemab\u6f5c\u5728\u4e34\u5e8a\u548c\u793e\u4f1a\u7ecf\u6d4e\u5b66\u4ef7\u503c\u7684\u6df1\u523b\u89c1\u89e3\u3002\u6211\u4eec\u5f88\u5feb\u5c31\u80fd\u83b7\u5f97Lecanemab III\u671fClarity AD\u7814\u7a76\u7684\u6570\u636e\uff0c\u4ece\u800c\u4e3a\u6a21\u578b\u8f93\u5165\u63d0\u4f9b\u4fe1\u606f\u5e76\u5b8c\u5584\u7814\u7a76\u7ed3\u679c\u3002\u5982\u679cLecanemab\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u7684\u6279\u51c6\uff0c\u536b\u6750\u53ef\u80fd\u4f1a\u4f7f\u7528\u8fd9\u4e2a\u6846\u67b6\u4ee5\u53ca\u5176\u4ed6\u8003\u8651\u56e0\u7d20\uff08\u5982\u53ef\u8d1f\u62c5\u6027\u3001\u536b\u751f\u7cfb\u7edf\u7684\u53ef\u6301\u7eed\u6027\u7b49\uff09\u6765\u786e\u5b9aVBP\u3002<\/p>\n \u536b\u6750\u682a\u5f0f\u4f1a\u793e\u9ad8\u7ea7\u526f\u603b\u88c1\u3001\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u7814\u53d1\u4e1a\u52a1\u603b\u88c1\u517c\u5168\u7403\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u8d1f\u8d23\u4eba\u3001\u536b\u6750\u7f8e\u56fd\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98Ivan Cheung\u8868\u793a\uff1a\u201c\u536b\u6750\u7684\u76ee\u6807\u662f\u521b\u9020\u65b0\u7597\u6cd5\uff0c\u6bd4\u5982\u6211\u4eec\u7684\u6297\u03b2\u6dc0\u7c89\u6837\u539f\u7ea4\u7ef4\u6297\u4f53Lecanemab\uff0c\u8fd9\u53ef\u80fd\u6709\u52a9\u4e8e\u51cf\u8f7b\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u60a3\u8005\u53ca\u5176\u5bb6\u4eba\u7684\u7126\u8651\u3002\u5bf9\u4e8e\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\uff0c\u91cd\u8981\u7684\u662f\u8bc4\u4ef7\u7597\u6cd5\u7684\u6574\u4f53\u4ef7\u503c\uff0c\u4e0d\u4ec5\u8981\u8003\u8651\u533b\u7597\u6210\u672c\uff0c\u8fd8\u8981\u8003\u8651\u5de8\u5927\u7684\u793e\u4f1a\u6210\u672c\u3002\u4f5c\u4e3a\u536b\u6750\u201c\u5173\u5fc3\u4eba\u7c7b\u5065\u5eb7<\/em>\u4f7f\u547d\u3001\u4fe1\u4efb\u548c\u900f\u660e\u5ea6\u201d\u627f\u8bfa\u7684\u4e00\u90e8\u5206\uff0c\u6211\u4eec\u5c06\u7ee7\u7eed\u516c\u5e03\u6709\u5173Lecanemab\u7684\u6570\u636e\u548c\u4fe1\u606f\uff0c\u5e76\u671f\u5f85\u4eca\u5e74\u79cb\u5b63\u80fd\u591f\u5206\u4eabLecanemab\u9a8c\u8bc1\u6027III\u671fClarity AD\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7ed3\u679c\u3002\u201d<\/p>\n \u536b\u6750\u4e8e2022\u5e745\u6708\u5728\u52a0\u901f\u6279\u51c6\u901a\u9053\u4e0b\u5b8c\u6210\u5411FDA\u6eda\u52a8\u63d0\u4ea4Lecanemab\u6cbb\u7597\u65e9\u671fAD\u7684\u751f\u7269\u5236\u54c1\u8bb8\u53ef\u7533\u8bf7\uff08BLA\uff09\u3002Lecanemab\u6cbb\u7597\u65e9\u671fAD\u7684III\u671fClarity AD\u4e34\u5e8a\u7814\u7a76\u6b63\u5728\u8fdb\u884c\u4e2d\uff0c\u5e76\u4e8e2021\u5e743\u6708\u5b8c\u6210\u62db\u52df\uff0c\u5171\u5165\u7ec41795\u540d\u60a3\u8005\u3002Clarity AD\u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\u6570\u636e\u5c06\u4e8e2022\u5e74\u79cb\u5b63\u516c\u5e03\u3002FDA\u5df2\u7ecf\u540c\u610f\uff0c\u5728Clarity AD\u7814\u7a76\u5b8c\u6210\u540e\u53ef\u5c06\u6240\u5f97\u7ed3\u679c\u4f5c\u4e3a\u786e\u8bc1\u6027\u7814\u7a76\u7684\u7ed3\u679c\uff0c\u4ee5\u9a8c\u8bc1Lecanemab\u7684\u4e34\u5e8a\u83b7\u76ca\u3002\u536b\u6750\u53ef\u80fd\u4e8e2022\u8d22\u5e74\u5185\uff08\u622a\u81f32023\u5e743\u6708\uff09\u5411FDA\u63d0\u4ea4Lecanemab\u7684\u5168\u9762\u6279\u51c6\u7533\u8bf7\uff08\u5177\u4f53\u53d6\u51b3\u4e8eClarity AD\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7ed3\u679c\uff09\u30022022\u5e743\u6708\uff0c\u536b\u6750\u5f00\u59cb\u5728\u65e5\u672c\u6839\u636e\u4e8b\u5148\u8bc4\u4f30\u54a8\u8be2\u5236\u5ea6\u5411\u836f\u54c1\u548c\u533b\u7597\u5668\u68b0\u7ba1\u7406\u5c40\uff08PMDA\uff09\u63d0\u4ea4\u7533\u8bf7\u6570\u636e\uff0c\u4ee5\u4f7fLecanemab\u5c3d\u65e9\u83b7\u6279\uff0c\u5e76\u5c06\u6839\u636e\u536b\u67502022\u8d22\u5e74\u5185Clarity AD\u7814\u7a76\u7684\u7ed3\u679c\u7533\u8bf7\u751f\u4ea7\u548c\u4e0a\u5e02\u8bb8\u53ef\u3002\u53e6\u5916\uff0c\u6839\u636eClarity AD\u7814\u7a76\u7684\u7ed3\u679c\uff0c\u536b\u6750\u8ba1\u5212\u4e8e2022\u8d22\u5e74\u5728\u6b27\u6d32\u63d0\u4ea4\u65b0\u836f\u7533\u8bf7\u3002<\/p>\n \u672c\u65b0\u95fb\u7a3f\u8ba8\u8bba\u7684\u662f\u6b63\u5728\u5f00\u53d1\u7684\u836f\u7269\u7684\u7814\u7a76\u7528\u9014\uff0c\u65e0\u610f\u4f20\u8fbe\u5173\u4e8e\u7597\u6548\u6216\u5b89\u5168\u6027\u7684\u7ed3\u8bba\u3002\u6211\u4eec\u5e76\u4e0d\u4fdd\u8bc1\u6b64\u8bd5\u9a8c\u7528\u836f\u7269\u5c06\u6210\u529f\u5b8c\u6210\u4e34\u5e8a\u5f00\u53d1\u6216\u83b7\u5f97\u536b\u751f\u5f53\u5c40\u7684\u6279\u51c6\u3002<\/p>\n *AD\u7684\u6807\u51c6\u6cbb\u7597\uff08SoC\uff09\u76ee\u524d\u5305\u62ec\u751f\u6d3b\u65b9\u5f0f\u8c03\u6574\u548c\u75c7\u72b6\u7684\u836f\u7269\u6cbb\u7597\u3002<\/p>\n **\u8d28\u91cf\u8c03\u6574\u751f\u547d\u5e74\uff08QALY\uff09\u662f\u4e00\u79cd\u8861\u91cf\u5065\u5eb7\u7ed3\u5c40\u7684\u6307\u6807\u3002\u7531\u4e8e\u5065\u5eb7\u662f\u751f\u547d\u957f\u5ea6\uff08\u5373\u6570\u91cf\uff09\u548c\u751f\u6d3b\u8d28\u91cf\uff08QOL\uff09\u7684\u51fd\u6570\uff0cQALY\u7684\u4ea7\u751f\u5219\u662f\u4e3a\u4e86\u5c06\u8fd9\u4e9b\u5c5e\u6027\u7684\u503c\u5408\u5e76\u4e3a\u4e00\u4e2a\u4e2a\u4f53\u6307\u6570\u3002\u4e00\u4e2aQALY\u7b49\u4e8e\u5904\u4e8e\u5b8c\u5168\u5065\u5eb7\u72b6\u6001\u7684\u4e00\u5e74\u3002QALY\u8bc4\u5206\u8303\u56f4\u4ece1\uff08\u5b8c\u5168\u5065\u5eb7\uff09\u81f30\uff08\u6b7b\u4ea1\uff09\u3002\u4f8b\u5982\uff0c\u4e00\u9879\u65b0\u7684\u5e72\u9884\u63aa\u65bd\u53ef\u80fd\u4f1a\u589e\u52a03\u5e74\u7684\u5bff\u547d\uff0c\u5e76\u5c06\u751f\u6d3b\u8d28\u91cf\u6539\u558470%\uff08QALY\u8bc4\u5206\u4e3a2.1\uff09\uff0c\u800c\u73b0\u6709\u7684\u5e72\u9884\u63aa\u65bd\u53ef\u80fd\u4f1a\u589e\u52a03\u5e74\u7684\u5bff\u547d\uff0c\u4f46QOL \u4ec5\u53ef\u6539\u558450%\uff08QALY\u8bc4\u5206\u4e3a1.5\uff09\uff0c\u6240\u4ee5\u8fd9\u9879\u65b0\u5e72\u9884\u63aa\u65bd\u7684\u589e\u91cfQALY\u5c06\u4e3a0.6 QALY\u3002<\/p>\n ***\u6b63\u5f0f\u548c\u975e\u6b63\u5f0f\u62a4\u7406\u8d39\u7528\u4e0d\u5305\u62ecLecanemab\u836f\u7269\u8d39\u7528\u3002<\/p>\n ****\u5728\u60c5\u666f\u5206\u6790\u4e2d\u63a2\u8ba8\u4e86\u66ff\u4ee3\u7684\u6cbb\u7597\u505c\u6b62\u89c4\u5219\uff0c\u5373\u57281.5\u5e74\u30013\u5e74\u548c5\u5e74\u7684\u56fa\u5b9a\u671f\u9650\u540e\u505c\u6b62Lecanemab\u6cbb\u7597\u3002<\/p>\n *****ICER\u662f\u7f8e\u56fd\u7684\u4e00\u5bb6\u975e\u8425\u5229\u6027\u7814\u7a76\u7ec4\u7ec7\uff0c\u4e13\u6ce8\u4e8e\u8bc4\u4f30\u5904\u65b9\u836f\u3001\u533b\u7597\u6d4b\u8bd5\u3001\u5668\u68b0\u548c\u536b\u751f\u7cfb\u7edf\u63d0\u4f9b\u521b\u65b0\u7684\u4e34\u5e8a\u548c\u7ecf\u6d4e\u4ef7\u503c\u8bc1\u636e\u3002<\/p>\n <\/p>\n 1 <\/sup>Kansal AR, Tafazzoli A, Ishak KJ, Krotneva S. Alzheimer’s disease Archimedes condition-event simulator: Development and validation.Alzheimers Dement <\/em>(NY).2018;4:76-88.Published 2018 Feb 16. doi:10.1016\/j.trci.2018.01.001.<\/p>\n 2<\/sup> Tafazzoli and Kansal. Disease simulation in drug development, External validation confirms benefit in decision making.The Evidence Forum.2018.<\/p>\n https:\/\/www.evidera.com\/wp-content\/uploads\/2018\/10\/07-Disease-Simulation-in-Drug-Development_Fall2018.pdf<\/u><\/p>\n 3<\/sup> Tafazzoli A, Weng J, Sutton K, et al. Validating simulated cognition trajectories based on ADNI against 436 trajectories from the National Alzheimer’s Coordinating Center (NACC) dataset.11th edition of Clinical Trials on 437 Alzheimer’s Disease (CTAD); Barcelona, Spain: 2018.<\/p>\n 4 <\/sup>Tahami Monfared AA, Tafazzoli A, Ye W, Chavan A, Zhang Q. Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer\u2019s Disease Using Simulation Modeling. Neurol Ther <\/em>11, 863\u2013880 (2022). https:\/\/link.springer.com\/article\/10.1007\/s40120-022-00350-y.<\/p>\n 5<\/sup> ICER Value Framework 2020-2023. 2022.ICER_2020_2023_VAF_02032022.pdf<\/u><\/p>\n 6 <\/sup>Alzheimer’s Association. 2022 Alzheimer\u2019s Disease Facts and Figures 2022 Available from: alzheimers-facts-and- figures.pdf.<\/p>\n <\/p>\n \u5a92\u4f53\u54a8\u8be2\uff1a<\/strong><\/p>\n \u516c\u5171\u5173\u7cfb\u90e8\uff0c<\/p>\n \u536b\u6750\u682a\u5f0f\u4f1a\u793e<\/p>\n +81-(0)3-3817-5120<\/p>\n <\/p>\n \u536b\u6750\u7f8e\u56fd<\/p>\n Libby Holman<\/p>\n Libby_Holman@Eisai.com<\/p>\n 201-753-1945<\/p>\n","protected":false},"excerpt":{"rendered":" \u7b2c\u4e8c\u7bc7\u4f7f\u7528\u6a21\u62df\u6a21\u578b\u7814\u7a76Lecanemab\u6cbb\u7597\u65e9\u671f\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u60a3\u8005\u7684\u6f5c\u5728\u4ef7\u503c\u7684\u6587\u7ae0<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-6320","post","type-post","status-publish","format-standard","hentry","category-news-zh"],"_links":{"self":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts\/6320"}],"collection":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/comments?post=6320"}],"version-history":[{"count":5,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts\/6320\/revisions"}],"predecessor-version":[{"id":6322,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts\/6320\/revisions\/6322"}],"wp:attachment":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/media?parent=6320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/categories?post=6320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/tags?post=6320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}